0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Marek's Disease Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26J6007
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Marek s Disease Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Marek's Disease Vaccine Market Research Report 2025

Code: QYRE-Auto-26J6007
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Marek's Disease Vaccine Market

The global market for Marek's Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Marek"s Disease Vaccine is used to prevent Marek"s disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
North American market for Marek's Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Marek's Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Marek's Disease Vaccine include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Beijing Huadu Shihua Biological Products Co., Ltd., Guangxi Lichengdong Biological Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Marek's Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marek's Disease Vaccine.
The Marek's Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Marek's Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marek's Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Marek's Disease Vaccine Market Report

Report Metric Details
Report Name Marek's Disease Vaccine Market
Segment by Type
  • Bivalent Vaccine
  • Monovalent Vaccine
Segment by Application
  • Veterinary Pharmacy
  • Online Sale
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Beijing Huadu Shihua Biological Products Co., Ltd., Guangxi Lichengdong Biological Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Marek's Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Marek's Disease Vaccine Market report?

Ans: The main players in the Marek's Disease Vaccine Market are Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Beijing Huadu Shihua Biological Products Co., Ltd., Guangxi Lichengdong Biological Co., Ltd.

What are the Application segmentation covered in the Marek's Disease Vaccine Market report?

Ans: The Applications covered in the Marek's Disease Vaccine Market report are Veterinary Pharmacy, Online Sale, Others

What are the Type segmentation covered in the Marek's Disease Vaccine Market report?

Ans: The Types covered in the Marek's Disease Vaccine Market report are Bivalent Vaccine, Monovalent Vaccine

1 Marek's Disease Vaccine Market Overview
1.1 Product Definition
1.2 Marek's Disease Vaccine by Type
1.2.1 Global Marek's Disease Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bivalent Vaccine
1.2.3 Monovalent Vaccine
1.3 Marek's Disease Vaccine by Application
1.3.1 Global Marek's Disease Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Marek's Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Marek's Disease Vaccine Revenue 2020-2031
1.4.2 Global Marek's Disease Vaccine Sales 2020-2031
1.4.3 Global Marek's Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Marek's Disease Vaccine Market Competition by Manufacturers
2.1 Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Marek's Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Marek's Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Marek's Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Marek's Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Marek's Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Marek's Disease Vaccine, Date of Enter into This Industry
2.8 Global Marek's Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Marek's Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Marek's Disease Vaccine Players Market Share by Revenue
2.8.3 Global Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Marek's Disease Vaccine Market Scenario by Region
3.1 Global Marek's Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Marek's Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Marek's Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Marek's Disease Vaccine Sales by Region: 2026-2031
3.3 Global Marek's Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Marek's Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Marek's Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Marek's Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Marek's Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Marek's Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Marek's Disease Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Marek's Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Marek's Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Marek's Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Marek's Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Marek's Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Marek's Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Marek's Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Marek's Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Marek's Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Marek's Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Marek's Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Marek's Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Marek's Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Marek's Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Marek's Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Marek's Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Marek's Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Marek's Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Marek's Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Marek's Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Marek's Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Marek's Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Marek's Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Marek's Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Marek's Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Marek's Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Marek's Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Marek's Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Marek's Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Marek's Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Marek's Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Marek's Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Marek's Disease Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ceva
6.2.1 Ceva Company Information
6.2.2 Ceva Description and Business Overview
6.2.3 Ceva Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ceva Marek's Disease Vaccine Product Portfolio
6.2.5 Ceva Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Marek's Disease Vaccine Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
6.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
6.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Description and Business Overview
6.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
6.6 Merial
6.6.1 Merial Company Information
6.6.2 Merial Description and Business Overview
6.6.3 Merial Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merial Marek's Disease Vaccine Product Portfolio
6.6.5 Merial Recent Developments/Updates
6.7 Ruipu Biopharmaceutical Co., Ltd.
6.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
6.7.2 Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.7.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
6.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
6.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
6.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
6.9 Beijing Huadu Shihua Biological Products Co., Ltd.
6.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
6.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Description and Business Overview
6.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments/Updates
6.10 Guangxi Lichengdong Biological Co., Ltd.
6.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
6.10.2 Guangxi Lichengdong Biological Co., Ltd. Description and Business Overview
6.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.10.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Marek's Disease Vaccine Industry Chain Analysis
7.2 Marek's Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Marek's Disease Vaccine Production Mode & Process Analysis
7.4 Marek's Disease Vaccine Sales and Marketing
7.4.1 Marek's Disease Vaccine Sales Channels
7.4.2 Marek's Disease Vaccine Distributors
7.5 Marek's Disease Vaccine Customer Analysis
8 Marek's Disease Vaccine Market Dynamics
8.1 Marek's Disease Vaccine Industry Trends
8.2 Marek's Disease Vaccine Market Drivers
8.3 Marek's Disease Vaccine Market Challenges
8.4 Marek's Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Marek's Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Marek's Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Marek's Disease Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Marek's Disease Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Marek's Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Marek's Disease Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Marek's Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Marek's Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Marek's Disease Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Marek's Disease Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Marek's Disease Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Marek's Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marek's Disease Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Marek's Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Marek's Disease Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Marek's Disease Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Marek's Disease Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Marek's Disease Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Marek's Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Marek's Disease Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Marek's Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Marek's Disease Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Marek's Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Marek's Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Marek's Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Marek's Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Marek's Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Marek's Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Marek's Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Marek's Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Marek's Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Marek's Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Marek's Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Marek's Disease Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Marek's Disease Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Marek's Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Marek's Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Marek's Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Marek's Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Marek's Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Marek's Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Marek's Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Marek's Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Marek's Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Marek's Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Marek's Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Marek's Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Marek's Disease Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Marek's Disease Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Marek's Disease Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Marek's Disease Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Marek's Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Marek's Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Marek's Disease Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Marek's Disease Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Marek's Disease Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Marek's Disease Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Marek's Disease Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Marek's Disease Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Marek's Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Marek's Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Marek's Disease Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Marek's Disease Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Marek's Disease Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Ceva Company Information
 Table 76. Ceva Description and Business Overview
 Table 77. Ceva Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ceva Marek's Disease Vaccine Product
 Table 79. Ceva Recent Developments/Updates
 Table 80. Zoetis Company Information
 Table 81. Zoetis Description and Business Overview
 Table 82. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zoetis Marek's Disease Vaccine Product
 Table 84. Zoetis Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim Marek's Disease Vaccine Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
 Table 91. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Description and Business Overview
 Table 92. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product
 Table 94. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
 Table 95. Merial Company Information
 Table 96. Merial Description and Business Overview
 Table 97. Merial Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merial Marek's Disease Vaccine Product
 Table 99. Merial Recent Developments/Updates
 Table 100. Ruipu Biopharmaceutical Co., Ltd. Company Information
 Table 101. Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product
 Table 104. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
 Table 106. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
 Table 107. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product
 Table 109. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
 Table 110. Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
 Table 111. Beijing Huadu Shihua Biological Products Co., Ltd. Description and Business Overview
 Table 112. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product
 Table 114. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments/Updates
 Table 115. Guangxi Lichengdong Biological Co., Ltd. Company Information
 Table 116. Guangxi Lichengdong Biological Co., Ltd. Description and Business Overview
 Table 117. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product
 Table 119. Guangxi Lichengdong Biological Co., Ltd. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Marek's Disease Vaccine Distributors List
 Table 123. Marek's Disease Vaccine Customers List
 Table 124. Marek's Disease Vaccine Market Trends
 Table 125. Marek's Disease Vaccine Market Drivers
 Table 126. Marek's Disease Vaccine Market Challenges
 Table 127. Marek's Disease Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Marek's Disease Vaccine
 Figure 2. Global Marek's Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Marek's Disease Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Bivalent Vaccine Product Picture
 Figure 5. Monovalent Vaccine Product Picture
 Figure 6. Global Marek's Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Marek's Disease Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Veterinary Pharmacy
 Figure 9. Online Sale
 Figure 10. Others
 Figure 11. Global Marek's Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Marek's Disease Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Marek's Disease Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Marek's Disease Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Marek's Disease Vaccine Report Years Considered
 Figure 16. Marek's Disease Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Marek's Disease Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Marek's Disease Vaccine Players: Market Share by Revenue in Marek's Disease Vaccine in 2024
 Figure 19. Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Marek's Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Marek's Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Marek's Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Marek's Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Marek's Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Marek's Disease Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Marek's Disease Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Marek's Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Marek's Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Marek's Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Marek's Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Marek's Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Marek's Disease Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Marek's Disease Vaccine by Type (2020-2031)
 Figure 55. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Marek's Disease Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Marek's Disease Vaccine by Application (2020-2031)
 Figure 58. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Marek's Disease Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS